Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Diplomat Pharmacy Inc (DPLO)

Diplomat Pharmacy Inc (DPLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Diplomat Pharmacy Inc 4100 S. SAGINAW ST. FLINT MI 48507 USA

www.diplomatpharmacy.com P: 888-720-4450

Description:

Diplomat Pharmacy, Inc. operates as an independent specialty pharmacy in the United States. It aids in the dispensing, delivery, dosing and reimbursement of clinically intensive and specialty drugs. The company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat Pharmacy, Inc. is headquartered in Flint, Michigan.

Key Statistics

Overview:

Market Capitalization, $K 304,004
Shares Outstanding, K 76,001
Annual Sales, $ 5,493 M
Annual Net Income, $ -302,270 K
Last Quarter Sales, $ 1,301 M
Last Quarter Net Income, $ -177,280 K
60-Month Beta 0.82
% of Insider Shareholders 24.10%
% of Institutional Shareholders 83.92%
Float, K 57,685
% Float 75.90%

Growth:

1-Year Return -70.65%
3-Year Return -72.60%
5-Year Return -84.70%
5-Year Revenue Growth 262.51%
5-Year Earnings Growth 42.86%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.35 on 11/12/19
Latest Earnings Date 03/20/20
Earnings Per Share ttm -0.54
EPS Growth vs. Prev Qtr -33.33%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

DPLO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -12.15%
Return-on-Assets % -3.05%
Profit Margin % -5.50%
Debt/Equity 0.18
Price/Sales 0.06
Price/Cash Flow 0.87
Price/Book 2.31
Book Value/Share 1.73
Interest Coverage -6.38
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar